Drugs Made In America Acquisition II Corp. Unit
Drugs Made In America Acquisition II Corp. Unit（DMIIU）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · DMIIU · 截至 Jun 9, 2026
关键指标
探索 Drugs Made In America Acquisition II Corp. Unit 数据
dmiiu stock data · financials竞争对手与同行
dmiiu competitorsDMIIU
EIC
GAIN
GAM
MSIF
NCDL股票表现
完整历史关于 Drugs Made In America Acquisition II Corp. Unit
Drugs Made In America Acquisition II Corp. Unit DMIIU is a Special Purpose Acquisition Company (SPAC), operating as a blank check firm established in the Cayman Islands. Its core objective is to identify and complete a merger or acquisition with an…
what is drugs made in america acquisition ii corp. unit · dmiiu stock overview · drugs made in america acquisition ii corp. unit company profile · who is drugs made in america acquisition ii corp. unit ceo · dmiiu NASDAQ · drugs made in america acquisition ii corp. unit headquarters · drugs made in america acquisition ii corp. unit business segments
关于股票概览与关键数据
Drugs Made In America Acquisition II Corp. Unit（DMIIU）是 Asset Management 行业的 Financial Services 类公司，于 Sep 25, 2025 在 NASDAQ 上市。截至最近交易日，DMIIU 股价为 $10.22，市值约为 $711.1M。过去12个月累计回报 +2.35%，年初至今回报 +2.05%。
常见问题
截至最近一个交易日，Drugs Made In America Acquisition II Corp. Unit（DMIIU）股价为 $10.22，在 NASDAQ 上市，52周区间为 $9.94 – $10.80。